Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
MedsGo Class CHistory of QT prolongation; known history of myasthenia gravis.
Yes
Fenflid Infections
Known positive evidence of fetus/lactating ability. Maintaining good health by taking adequate fluid intake while breastfeeding.
Milk not used by patients with hepatic impairment. Do not use if breastfeeding.
Cipro (Ciprofloxacin) can be purchased by calling +1-888-704-0408 and talking with a customer service representative, or by placing an online order at liferxpharmacy.com. Customer Support is also aided by using the chat feature. For additional information, visit the "How to Order" page on liferxpharmacy.com.
Cipro (Ciprofloxacin) is a medication that can only be purchased with a doctors prescription. While processing your order for the medication, it is necessary to get a valid prescription from your doctor The prescription can be scanned, emailed, or uploaded at liferxpharmacy.com or fax on +1-800-986-4751 Alternatively, if you like, we can even contact your doctor to obtain a valid prescription.
The maximum amount of Cipro (Ciprofloxacin) can be ordered at one time is a 90-day supply. The amount that can be ordered is dependent on the instructions and quantity mentioned on your medical prescription. Refilling alternate is always available for future needs.
It is a completely safe and secure choice to order your medicine from us. We function similarly alike any other traditional pharmacy, intending to serve safe and affordable prescription medicines. Our associated pharmacists are functional in many countries and are completely licensed and certified.
Cipro (Ciprofloxacin) is available in both generic and brand form. Generic medicines contain the same active components as brand-name pharmaceuticals have. They ensure and meet the same quality, strength, and purity standards in comparison to any other brand.
Yes. We deliver all around the United States and other major countries.
LifeRx pharmacy makes it simple to refill your medication. By going to your accounts reorder section, you can easily place a refill option available online. You may examine your prior orders and choose which prescriptions order needs to be refilled. To order a refill, you can also call us and chat with one of our customer service representatives. Our live chat is also one of the convenient ways to reach out to us while placing a refill order.
We do not automatically refill prescriptions as it might be the case where you may no longer be taking the same medicines or your doctor may have revised your dose, among other things. However, we do offer a helpful refill reminder service. Based on your prescription history, we may call or email you to let you know when the ideal time is to place a refill order.
Approved pharmacyRecogniseDo you qualify for a refill order?We are here to help. You may now place a refill order - even if the medication you are seeking has been taken less time than that required by your doctor. We ensure that you are within options and conditions and that your relevant medical, psychiatric, or diabetes prescription is being taken.
DiscloseRef refill details are case dependent and include specific conditions that will be listed below.Ref refill details:If you have not been prescribed a medication, we will continue to administer follow-up visits to evaluate the improvement that has occurred since taking the medication and if necessary re-assess how the medication is going to affect you.
Chloramphenicol
The use of this drug is contraindicated. Patients with severe renal or hepatic impairment should be started onhtmciprofloxacin at a dose of 1 mg per day for 48 hours. Patients with severe heart failure (or right ventricular failure on recent MI) should be started onhtmciprofloxacin at a dose of 10 mg per day for 10 days. For patients with severe renal or hepatic impairment, or for those with other concomitant diseases, the recommended starting dose is 10 mg per day for 10 days. For the treatment of children with glaucoma on therapy (GSK), the dose is 1 mg per day for 5 days. For the treatment of children with recurrent glaucoma on therapy (RAGE), the dose is 1 mg per day for 5 days. For the treatment of patients with active tuberculosis (TB), the dose is 1 mg per day for 5 days. For the treatment of patients with active typhoid fever (T fever) or severe respiratory diseases (asthma), the dose is 1 mg per day for 5 days. For the treatment of patients with anthrax on therapy ( Part 1), the dose is 1 mg per day for 5 days. For the treatment of patients with cytomegalovirus (CMV) infection, the dose is 1 mg per day for 5 days. For the treatment of patients with mycobacterium rica (MMR), the dose is 1 mg per day for 5 days. For the treatment of patients with paracetamol-induced migraine, the dose is 1 mg per day for 5 days. For the treatment of patients with asthma, the dose is 1 mg per day for 5 days. For the treatment of patients with psoriasis, the dose is 1 mg per day for 5 days. For the treatment of psoriatic arthritis, the dose is 1 mg per day for 5 days. For the treatment of systemic lupus erythematosus (SLE), the dose is 1 mg per day for 5 days. For the treatment of systemic sclerosis (SSE), the dose is 1 mg per day for 5 days. For the treatment of renal impairment, the dose is 1 mg per day for 5 days. The prescribed dose is 1 mg per day for 5 days. The recommended starting dose is 1 mg per day for 5 days. The recommended starting dose for patients with glaucoma on therapy (GSK) is 2 gm per day for 2 weeks. For patients with severe renal impairment, the dose is 2 gm per day for 2 weeks. The dose for patients with active tuberculosis (TB) on therapy (Part 2) is 2 gm per day for 2 weeks. The recommended starting dose is 2 gm per day for 2 weeks. The recommended starting dose for patients with CMV infection is 2 gm per day for 2 weeks. For the treatment of children with active typhoid fever (T fever), the dose is 2 gm per day for 2 weeks. For the treatment of children with mycobacterium rica (MMR), the dose is 2 gm per day for 2 weeks. For the treatment of children with paracetamol-induced migraine, the dose is 2 gm per day for 2 weeks. For the treatment of pediatric patients with asthma or chronic obstructive pulmonary disease (COPD), the dose is 2 gm per day for 2 weeks. The recommended starting dose for patients with cystic fibrosis on therapy (Part 3) is 2 gm per day for 2 weeks. The recommended starting dose for patients with severe hepatic impairment is 2 gm per day for 2 weeks. The dose for children with renal impairment is 2 gm per day for 2 weeks. The recommended starting dose for patients with severe renal impairment is 2 gm per day for 2 weeks. The dose for children with other diseases is 2 gm per day for 2 weeks. For the treatment of children with cystic fibrosis on therapy (Part 4) the dose is 2 gm per day for 2 weeks. The recommended starting dose for children with other diseases is 2 gm per day for 2 weeks.
Background: The antibiotic Ciprofloxacin has been the first-line treatment for bacterial infections in the world. However, the clinical impact of this treatment has been limited. This study aimed to develop a new formulation of Ciprofloxacin hydrochloride (Cipro) that could be applied for the development of an active pharmaceutical ingredient (API) for the treatment of bacterial infections. Materials and Methods: A new formulation of Cipro containing the ciprofloxacin hydrochloride (Cipro-HCl) was prepared. The Cipro-HCl had a molecular weight of 5,872.9, and its chemical structure was confirmed by nuclear magnetic resonance (NMR) and mass spectrometry. Results: The ciprofloxacin hydrochloride (Cipro-HCl) was successfully prepared with a yield of 74.0% and an average solubility of 9.8mg/ml. The ciprofloxacin hydrochloride-formulation was carried out in water with a pH of 3.0. This method resulted in a good solubility of Cipro (9.0mg/ml) in water for oral administration. Conclusion: The ciprofloxacin hydrochloride (Cipro-HCl) was successfully prepared. The ciprofloxacin hydrochloride (Cipro-HCl) was successfully formulated and its solubility in water was evaluated in this study.
Cipro, Cipro-HCl, drug, drug product, hydrochloride, hydrophilic, antibacterial, antimicrobial, antibiogram
The development of antibiotics has led to the discovery of a wide range of antimicrobial agents, among them ciprofloxacin, levofloxacin, amoxicillin, and trimethoprim (SMZ). However, the clinical efficacy of these agents has been limited due to their low solubility and low bioavailability. In the past few years, ciprofloxacin has been the most widely used antibiotic in the world. Due to its low solubility and poor bioavailability, it has become a very effective treatment option. However, some resistance mechanisms, such as increased lipolysis, reduced solubility, and limited solubility, have caused a lack of effective therapy. Hence, it is important to develop a new formulation of this antibiotic with a high bioavailability and low solubility. Ciprofloxacin is a broad-spectrum fluoroquinolone antibacterial and has the ability to reach high concentrations in a wide range of bacterial cells. It has been reported that ciprofloxacin could be effective against many bacterial infections in the gastrointestinal tract. It has been shown that it is a potent inhibitor ofin vitroandin vivopathogenesis of gram-negative bacteria. In this study, we prepared a new Cipro-HCl formulation of ciprofloxacin using a simple, cost-effective, and easy-to-use technology. The development of this novel formulation of Cipro-HCl was based on the previous literature and showed high bioavailability of ciprofloxacin.
Ciprofloxacin hydrochloride was prepared from the hydrochloride base of ciprofloxacin. The chemical structure of ciprofloxacin was confirmed by nuclear magnetic resonance (NMR) and mass spectrometry. The chemical structures of ciprofloxacin were confirmed by NMR and mass spectroscopy.
Anhydrous ethyl chloride (1:1), sodium hydroxide, sodium carbonate, hydrochloric acid, methanol, and water were purchased from Sigma-Aldrich (St. Louis, MO, USA) and acetonitrile was obtained from Merck (Darmstadt, Germany). The drug preparation was stored in the refrigerator at 4°C. A solution of the ciprofloxacin (5 mg/ml) was added to the solution of methanol and the pH was adjusted to 4.5 to 5.5 with freshly prepared water. The solution was mixed and stirred at room temperature for 24 h. The obtained suspension was filtered through a 0.
Pharmacist at the University of the Philippines - San Juan de Puerto
-
Abstract
Ciprofloxacin is a commonly used antibiotic for the treatment of bacterial infections. It is available in the U. S. as a powder. The main objective of this study was to compare the cost effectiveness of Ciprofloxacin (ciprofloxacin) in terms of price and availability. In this study, price, availability and cost effectiveness of ciprofloxacin were evaluated in terms of cost per unit, cost per dose, number of doses, number of days of treatment, total cost of the cost per dose and cost of the total cost of the cost for the antibiotic. The study used a fixed-dose combination of a standard tablet of ciprofloxacin and the standard pill of levofloxacin. The cost per unit, cost per dose, number of doses and number of days of treatment were calculated. The study showed that Ciprofloxacin can be an efficient and cost effective alternative to levofloxacin. In addition, cost per dose and cost per dose of levofloxacin can be reduced by 50% in some regions of the world.
Stade de France Pharmacy